Barclays PLC Agios Pharmaceuticals, Inc. Put Options Transaction History

Barclays PLC

3 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q1 2024 May 15, 2024	SELL	$21.32 - $34.81 $639,600 - $1.04 Million	-30,000 Reduced 50.0%	30,000 $877,000
Q4 2023 Feb 15, 2024	BUY	$19.97 - $24.53 $1.2 Million - $1.47 Million	60,000 New	60,000 $1.34 Million
Q1 2018 May 15, 2018	BUY	$59.83 - $86.53 $1.62 Million - $2.34 Million	27,000 New	27,000 $2.21 Million

232

58.1M

403K

469K

Ticker AGIO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 54,818,000
Market Cap $3.05B
Description
Agios Pharmaceuticals, Inc., a biopharmaceutical company, engages in the discovery and development of medicines in the field of cellular metabolism and adjacent areas of biology. The company offers PYRUKYND (mitapivat) an activator of both wild-type and a variety of mutant pyruvate kinase, PK, enzymes for the treatment of hemolytic anemias; and ...

Get notified when there are updates to the investment portfolio of Barclays PLC, based on Form 13F filings with the SEC.

Stay updated on Barclays PLC with notifications on news.